# Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis

> **NCT01411514** · PHASE4 · TERMINATED · sponsor: **Claudio Gobbi** · enrollment: 27 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01411514
- **Lead sponsor:** Claudio Gobbi
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Difficulties to recruit patients
- **Last updated:** 2015-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01411514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01411514, "Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01411514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*